Navigation Links
Helix BioPharma Corp. Announces Fiscal 2009 Results
Date:10/29/2009

f completion of enrolment for the Phase II AGW trial of Topical Interferon Alpha-2b; the timing of a future Phase I/II clinical study for L-DOS47 in Poland; sufficiency of the Company's cash reserves and expected cash flow from operations; and other information in future periods, which statements and information can be identified by the use of forward-looking terminology such as "plans", "expected", "intends"; "estimates", "next", "anticipated", "developing", "will" or variations thereon, or comparable terminology referring to future events or results. Although Helix believes that the expectations reflected in such forward-looking statements and information are reasonable, such statements and information involve risks and uncertainties, and undue reliance should not be placed on such statements and information. Certain material factors or assumptions are applied in making forward-looking statements and providing forward-looking information, including, but not limited to, patient recruitment rates and the timely and successful completion of ongoing clinical trials, GMP manufacturing and other activities; the timely provision of services by third parties; future revenue, costs and regulatory approvals. Important factors that could cause actual results to differ materially from these forward-looking statements and information include, without limitation, the Company's continuing need for additional capital, which may not be available in a timely manner or at all and which if not obtained will have a material adverse impact on the Company and its ability to continue, or if not obtained in a timely manner, may result in the Company's having to discontinue or delay one or more of its product development programs or other initiatives; uncertainty whether Topical Interferon Alpha-2b or L-DOS47 will be successfully developed and commercialized as a drug or at all; the risk that the FDA is not bound by its pre-IND meetings; uncertainty whether any of the timelines mentione
'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
2. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
3. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
4. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
6. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
7. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
8. PDL BioPharma Completes October 1 Special Dividend Payment
9. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
10. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
11. DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  When Ryan ... the side of his neck, he figured ... a couple weeks off from weight lifting. ... away.                               A series ... was referred to Michel Kliot, MD ...
(Date:5/21/2015)... CITY, Calif. , May 21, 2015  Cardica, Inc. ... 2015, new employee Greg Watson , the company,s vice ... shares of the company,s common stock, at a per share ... 20, 2015. The stock option was granted pursuant to Cardica, ... of directors in May 2015 under Rule 5653(c)(4) of the ...
(Date:5/21/2015)... 2015  Heidrick & Struggles (Nasdaq: HSII ), ... leadership consulting and culture shaping worldwide, ... practices announcing the addition of Tim Dietlin ... Dietlin has extensive life sciences and ... R&D, Medical and Commercial functions to increase productivity, drive ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4Cardica Announces New Employment Inducement Grant 2Heidrick Increases Healthcare and Life Sciences Expertise 2
... Orthopaedic Associates (AOA) in Largo, FL, has chosen to ... White Plume Technologies between Exscribe electronic health record ... system (PM system). EMRs can be powerful ... unfilled. White Plume Technologies bridges EMR gaps by ...
... DIA and the National Pharmaceutical Council (NPC) will ... Guide  Conference on March 14-15 at the Renaissance ... focus on the continued push for increased levels ... within health technology assessments, research planning and drug ...
Cached Medicine Technology:Alexander Orthopaedic Associates Chooses White Plume Technologies to Fill the EMR Gap 2DIA and National Pharmaceutical Council Will Host Two-Day Conference on Comparative Effectiveness Research 2
(Date:5/22/2015)... VIEW, California (PRWEB) May 22, 2015 Coco ... has set a RecordSetter.com World Record at the 104th running ... Libre coconut water ice luge served 315 people in one ... Bay to Breakers race is so true to the heart ... we felt bringing an ice luge to the finish line ...
(Date:5/22/2015)... Gateway Building Concepts is experienced with all forms of ... in include decks, additions, kitchen remodeling, interior renovations, exterior ... , The redesigned logo is a fresh modern ... includes two geometrical lines that represent the engineering aspect ... used with many things associated with the company. The ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Wimbledon Health ... vascular, electrocardiogram (EKG), echocardiogram and NCV testing , ... a highly respected All American National athlete, to the ... I find the high level of testing and information ... athlete and their athletic trainers, this way they can ...
(Date:5/22/2015)... NY (PRWEB) May 22, 2015 Steven ... Housing, Marc Zuluaga, has been selected by Consulting-Specifying Engineer ... The award winners are featured in the May/June issue ... 40 building industry professionals age 40 and younger who ... building community, as well as in other areas of ...
(Date:5/22/2015)... Calif. (PRWEB) May 22, 2015 Bryce ... opened Anaheim Fit Body Boot Camp, recently accepted his ... so quickly after the launch of his location evidences ... the Anaheim community. , Fit Body Boot Camp is ... boot camp franchise with hundreds of locations across North ...
Breaking Medicine News(10 mins):Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2
... complaint of a ,racing mind, is not just in patient,s ... primary insomnia have a specific neurochemical imbalance that makes it ... a new study says. , People with primary insomnia ... acid (GABA), a chemical that slows overall activity in many ...
... McGraw-Hill teams with ACEP to give emergency physicians access ... credit for ... Texas, Nov. 3 McGraw-Hill,Professional, a leading global provider ... partnered with American College of,Emergency Physicians, the largest membership ...
... STUDY ON DIABETIC FOOT ULCERS, PRINCETON, N.J., Nov. ... today the first study patient has been,entered into the ... of the 75-patient study, looking into the drug,s ability ... be completed,within 12 months. Currently, 4 US facilities have ...
... Hostess(R) Launches 100 Calorie ,Twinkie Bites, for Fans of ... Portion Controlled Size, KANSAS CITY, Mo., Nov. 3 ... of the snack cake that has been a,part of ... brand,that makes America,s most iconic snack cakes is now ...
... 3 Blue Cross and Blue Shield of,Minnesota ... president and,chief information officer for Cargill, to its ... human resources and finance and business development,committees., ... worldwide.,She is a member of Cargill,s corporate center, ...
... World,s Premiere Nanotechnology,Accelerator, HOUSTON, Nov. 3 ... of the Nano World Headquarters. Dr. Moore is ... has spent the past,seven years researching and promoting ... by Dr. Richard E. Smalley, Nobel Laureate from,Rice ...
Cached Medicine News:Health News:Primary Insomnia Tied to Brain Neurochemical Imbalance 2Health News:McGraw-Hill Professional and American College of Emergency Physicians Roll Out CME Functionality On AccessEmergency Medicine 2Health News:McGraw-Hill Professional and American College of Emergency Physicians Roll Out CME Functionality On AccessEmergency Medicine 3Health News:Derma Sciences Enrolls First Patient in DSC127 Phase II Study 2Health News:Derma Sciences Enrolls First Patient in DSC127 Phase II Study 3Health News:Derma Sciences Enrolls First Patient in DSC127 Phase II Study 4Health News:Derma Sciences Enrolls First Patient in DSC127 Phase II Study 5Health News:Could It Be? A 100 Calorie Twinkie(R)? 2Health News:Cargill Executive Joins Blue Cross Board of Trustees 2
Sealing tape, slightly stiffer than Polyolefin tape....
Sealing tape, slightly stiffer than Polyolefin tape. Certified RNase and DNase free....
Empore Sealing Tape Pads are ideal for covering a 96 well plate during storage or transfer to another work station. Not intended for use with auto-injectors....
Mylar Plate Sealers 100/Box...
Medicine Products: